XML 30 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories, Net
12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Inventories, net
5.
Inventories, net

 

The following table presents inventories, net (in thousands):

 

 

 

December 31

 

 

 

2022

 

 

2021

 

Raw materials

 

$

25,517

 

 

$

26,637

 

Work-in-process

 

 

23,934

 

 

 

14,748

 

Finished goods

 

 

9,995

 

 

 

19,950

 

Total

 

$

59,446

 

 

$

61,335

 

 

 

As of December 31, 2022 and December 31, 2021, included in finished goods inventory were $10.0 million and $18.6 million of HEPLISAV-B inventory, respectively. As of December 31, 2021, included in finished goods inventory were $1.3 million of CpG 1018 adjuvant inventory.

 

As of December 31, 2022, there we no prepaid manufacturing costs related to prepayments made to third-party manufacturers of CpG 1018 adjuvant. As of December 31 2021, we recorded $159.7 million of prepaid manufacturing costs related to prepayments made to third-party manufacturers of CpG 1018 adjuvant. During the year ended December 31, 2022, we recorded $34.3 million of inventory write-off to cost of sales - product, in connection with cancelled orders and the reduction in demand for CpG 1018 adjuvant associated with the Clover Supply Agreement, as amended (See Note 9).